It's not an attack to question your effectiveness and ask you to resolve inherent inconsistencies and inaccuracies in your predictions.
This may shock you but there is a huge chasm between "short" and "pumper."
If you think shorting GERN can slow it down you must think it needs a secondary to get IMET to market which means the stock is depressed for a reason and isn't going to $10 in weeks as you claim. Which is it?
lol. no. they can't apply until they get Phase II data and then FDA has 60 days to act on it. At earliest months away.
Now if only GERN was one of my top 10 portfolio drivers
If you want to put your faith in history you must also consider that GERN also gave those gains back up. You can't cherry pick those facts that suit you.
people should at least look at the IBB before making comments like this. GERN is tracking IBB tick for tick today.
Yes and every dollar it drops they make $40 million
There is a lot of room between 3.04 and 262. It can be undervalued--i agree with you--but the 262 predictions are counterproductive
Nice post and I agree. Let's hope he doesn't try to throw another ball in the air at the same time (acquisition) and both balls hit each other and neither goes in
50 billion market cap suuuuuurrrrre. Pass the dutchie to the left hand side
If you ignore all negative views, they don't exist and everyone is bullish! There is no spoon.